Chemical and biomolecular engineers at Georgia Tech have developed a plug-and-play platform that's simple, flexible, and easy ...
NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company ...
The GEAR platform aims to enhance the effectiveness of cancer therapies by preventing NK cell neutralization, providing a promising new approach to immuno-oncology. "We are thrilled to expand our ...
IN8bio (INAB) unveiled INB-600, its next generation gammadelta T cell-based TCE platform. It is designed to address one of the biggest shortcomings of current existing gammadelta TCEs ...
(RTTNews) - IN8bio, Inc. (INAB) announced the launch of its next-generation Gamma-Delta T-cell engager or TCE platform INB-600, designed to overcome the limitations of existing Gamma-Delta TCE ...